Archives: “Translational & Clinical”

Understanding the spectrum from preclinical psoriatic arthritis to early diagnosis of the disease

https://www.coltonconsortium.org/publications/understanding-the-spectrum-from-preclinical-psoriatic-arthritis-to-early-diagnosis-of-the-disease/

Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group

https://www.coltonconsortium.org/publications/vessel-wall-mri-in-giant-cell-arteritis-standardized-protocol-and-scoring-approach-developed-by-an-international-working-group/

Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function

https://www.coltonconsortium.org/publications/structural-insights-reveal-interplay-between-lag-3-homodimerization-ligand-binding-and-function/

Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade

https://www.coltonconsortium.org/publications/substantiation-of-trophoblast-transport-of-maternal-anti-ssa-ro-autoantibodies-in-fetuses-with-rapidly-progressive-cardiac-injury-implications-for-neonatal-fc-receptor-blockade/

T-bet+CD11c+ age-associated B cells resist BLyS- and CD20-targeted ablation in murine lupus models

https://www.coltonconsortium.org/publications/t-betcd11c-age-associated-b-cells-resist-blys-and-cd20-targeted-ablation-in-murine-lupus-models/

Targeted lipid nanoparticles containing IL-10 mRNA improve outcomes in experimental intracerebral hemorrhage

https://www.coltonconsortium.org/publications/targeted-lipid-nanoparticles-containing-il-10-mrna-improve-outcomes-in-experimental-intracerebral-hemorrhage/

Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes

https://www.coltonconsortium.org/publications/teplizumab-induces-persistent-changes-in-the-antigen-specific-repertoire-in-individuals-at-risk-for-type-1-diabetes/

The 2024 Vasculitis Foundation Quality Care Summit: seeking strategies to improve care for all patients

https://www.coltonconsortium.org/publications/the-2024-vasculitis-foundation-quality-care-summit-seeking-strategies-to-improve-care-for-all-patients/

Risk of relapse of antineutrophil cytoplasmic antibody–associated vasculitis in a randomized controlled trial of plasma exchange and glucocorticoids

https://www.coltonconsortium.org/publications/risk-of-relapse-of-antineutrophil-cytoplasmic-antibody-associated-vasculitis-in-a-randomized-controlled-trial-of-plasma-exchange-and-glucocorticoids/

Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials

https://www.coltonconsortium.org/publications/safety-and-efficacy-of-evobrutinib-in-relapsing-multiple-sclerosis-evolutionrms1-and-evolutionrms2-two-multicentre-randomised-double-blind-active-controlled-phase-3-trials/